Changeflow GovPing Healthcare IOPCL Implant Patent for AMD by Onpoint Vision
Routine Notice Added Final

IOPCL Implant Patent for AMD by Onpoint Vision

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Prosthetics (A61F)
Published March 25th, 2026
Detected April 1st, 2026
Email

Summary

The European Patent Office published patent application EP4132422A1 for Onpoint Vision, Inc., covering an Intraocular Pseudophakic Contact Lens (IOPCL)-based telescopic approach for treating age-related macular degeneration (AMD) and other eye disorders. The application designates 31 European states and was filed by inventors Kevin J. Cady and Kevin L. Waltz. This is a routine patent publication providing public notice of the intellectual property claim.

What changed

The EPO published patent application EP4132422A1 for an intraocular telescopic lens implant system designed to treat AMD and other visual disorders. The patent covers the IOPCL device architecture, optical configurations, and implantation methods. Key inventors are Kevin J. Cady and Kevin L. Waltz, with the application designating all relevant European member states for protection.

This patent publication does not impose any compliance obligations on market participants. Medical device manufacturers and healthcare providers should note this intellectual property claim for freedom-to-operate assessments and competitive intelligence purposes. No immediate regulatory action is required.

Source document (simplified)

← EPO Patent Bulletin

INTRAOCULAR PSEUDOPHAKIC CONTACT LENS (IOPCL)-BASED TELESCOPIC APPROACH FOR TREATING AGE-RELATED MACULAR DEGENERATION (AMD) OR OTHER EYE DISORDERS

Publication EP4132422A1 Kind: A1 Mar 25, 2026

Applicants

Onpoint Vision, Inc.

Inventors

CADY, Kevin J., WALTZ, Kevin L.

IPC Classifications

A61F 2/16 20060101AFI20240311BHEP A61F 9/00 20060101ALI20240311BHEP A61F 9/007 20060101ALI20240311BHEP A61F 9/011 20060101ALI20240311BHEP G02C 7/04 20060101ALI20240311BHEP G02C 7/06 20060101ALI20240311BHEP G02C 7/08 20060101ALI20240311BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

IOPCL-Based Telescopic Approach Treatment of AMD Eye Disorder Correction

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 25th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4132422A1

Who this affects

Applies to
Medical device makers Healthcare providers
Industry sector
3345 Medical Device Manufacturing 6211 Healthcare Providers
Activity scope
Patent Application Medical Device Licensing
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Medical Devices

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Prosthetics (A61F) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.